Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)
Study of the OPTtimum Duration of Acoustic Pulse ThromboLYSis ProcEdure in the Treatment of Acute Submassive Pulmonary Embolism
Sponsor: Boston Scientific Corporation
A PHASE4 clinical study on Pulmonary Embolism and Thrombosis, this trial is completed. The trial is conducted by Boston Scientific Corporation and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2021 — Sep 2021 [monthly]
Completed PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Oct 2019 — Sep 2020 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting · Phase: NA → PHASE4
-
Apr 2019 — Oct 2019 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
- EKOS Corporation
For direct contact, visit the study record on ClinicalTrials.gov .